U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

The British drugmaker may have succeeded in reviving an oral antibiotic previously rejected by the FDA when it was under development at Spero.

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...

Drug regulatory authority mandates disposal of unused opioid drugs and painkillers. This action aims to prevent misuse and ...

Tech oligarchs’ wildest visions of tomorrow amount to a modern secular theology that is both mesmerizing and, in his view, ...

Using neem tree extracts as a starting point, scientists have created several kinds of nanozymes and tested them for ...

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections and, in ...

Mortality risk was 34% lower among patients who underwent spirometry when initiating medication for a chronic respiratory condition.